The pairing of nicotine and caffeine represents the combination of two of the world’s most widely consumed psychoactive substances [1,2]. For centuries, people have combined their morning cup of coffee with a cigarette to this effect. Modern research is beginning to unravel the mechanistic underpinnings behind this association.
In this article, we will examine the background of this relationship, the underlying mechanisms, interactions, and broader consequences of the synergy between nicotine and caffeine.
Historical Background of Nicotine and Caffeine
Nicotine and caffeine have both played significant roles in our culture throughout human history. Nicotine, predominantly found in tobacco, became popular in the Americas before spreading to Europe and the wider world [3]. On the other hand, caffeine has been primarily consumed through tea, coffee, and cocoa. It is a symbol of alertness, social connection and bonding, and intellectual stimulation.
Both substances have journeyed across continents and become intertwined in our social rituals, leisure activities, and work routines.
The presence of a cigarette as part of the stereotypical “coffee break” is an image that has become embedded in popular culture during the 20th century. Research shows that caffeine consumption is strongly associated with smoking, and these behaviors often occur at the same time [4,5].
What are Nicotine and Caffeine?
Nicotine is the primary psychoactive agent found in tobacco leaves [3]. It acts as a stimulant by binding to nicotinic acetylcholine receptors (nAChR) in the brain. This interaction results in the release of several neurotransmitters, including dopamine, which is central to the brain’s reward circuitry. Other neurotransmitters released include norepinephrine, acetylcholine, serotonin, GABA, glutamate, and endorphins. These subsequently induce sensations of pleasure, stimulation, and mood modulation. The activation of nAChRs also leads to the establishment of new neural pathways which results in behavioral conditioning [3].
Caffeine is the most widely used central nervous system stimulant and psychoactive substance in the world. Its principal mode of action is as an adenosine receptor antagonist. Caffeine blocks adenosine, a neurotransmitter that invokes sleep and relaxation, therefore preventing the onset of drowsiness and boosting alertness and concentration. Caffeine can also influence other neurotransmitter systems (e.g., dopamine, serotonin), bringing about improved mood and enhanced cognitive function [6].
How do Nicotine and Caffeine Interact?
An intriguing aspect of nicotine and caffeine synergy lies in their interaction. Research has shown that tobacco smoke accelerates the metabolism of caffeine, speeding up its conversion to paraxanthine, theophylline, and theobromine via cytochrome P450 isoenzymes [7]. As a consequence, heavier cigarette consumption causally increases caffeine intake [8].
Neurotransmitter Systems and Reward Pathways
Aside from their metabolism, nicotine and caffeine are both psychomotor stimulants and are intertwined in their effects on brain chemistry. Both substances influence the dopaminergic pathways — the neural circuitry that is linked with pleasure, motivation, and reward. When nicotine binds to nAChRs it brings about a rapid release of dopamine. Likewise, the antagonism of adenosine receptors by caffeine indirectly acts on the same dopamine circuits by blocking the inhibitory effects of adenosine on neurotransmitter release [9,10]. Therefore, when both substances are consumed together, there is an augmented dopaminergic effect [11]. This effect boosts the pleasurable sensations associated with each substance but also reinforces the perception that both in combination are better than either substance on its own. This synergy perhaps accounts for why users report a more profound sense of alertness and satisfaction when they use nicotine and caffeine simultaneously.
How Nicotine and Caffeine Affect Cognition and Behavior
Both nicotine and caffeine have been independently associated with temporary improvements in function, including boosted attention span, faster reaction times, and enhanced memory consolidation [12,13]. You can read more on the cognitive effects of nicotine here.
When used together, the effects of nicotine and caffeine may be amplified. Research in rodents has shown that nicotine enhances the cognitive properties of caffeine through a significant increase in non-spatial working memory. On the other hand, caffeine enhances the effect of nicotine on memory and motor function [14].
Behaviorally, this synergy of caffeine and nicotine might be appealing in environments that require high amounts of concentration and performance, such as during long work hours or intensive study sessions. Of course, the benefits of nicotine in this setting might be outweighed by the negative health concerns if cigarettes are the route of administration [12].
Health Considerations of Nicotine and Caffeine Use
Despite these potential cognitive benefits, it’s very important to balance these against the associated health risks. Both nicotine and caffeine, when consumed in moderation, are generally deemed safe for most adults [15]. However, nicotine, when administered through tobacco products, carries significant health risks including addiction, lung cancer, cardiovascular disease, and the like [16]. While largely benign in comparison, caffeine can contribute to sleep disturbances and anxiety if overconsumed [17].
Individual Differences: Responders and Non-Responders
We all respond to nicotine and caffeine in different ways [18]. Individual factors such as genetics, lifestyle, and pre-existing health conditions can all significantly influence how we metabolize and respond to both of these psychoactive compounds [18,19]. Some might experience pronounced cognitive effects without any apparent side effects, for instance. This inherent variability underscores the importance of personalizing consumption habits and exercising caution when using them in combination.
Conclusion
The synergy between nicotine and caffeine shows the complex relationship between two powerful (and popular) psychoactive compounds that are deeply rooted in human culture. They both influence the dopaminergic pathways and thus exert powerful effects in terms of addiction and reward.
While the combined use of nicotine and caffeine can offer temporary cognitive and mood enhancements, it is accompanied by a set of health risks that should not be overlooked. The metabolic acceleration of caffeine by nicotine and the heightened dopaminergic response are mechanisms that, on one hand, provide an edge in alertness and performance but on the other hand, may lead to increased dependency and other adverse health outcomes.
The combination of these stimulants is likely to persist, especially given the fact that modern society places great value on productivity and social interaction. Future research will explore the mechanisms of this synergy in greater detail.
At Troscriptions, we have developed Blue Cannatine, a novel combination of low-dose, pharmaceutical-grade nicotine (1 mg), caffeine (50 mg), CBD, and methylene blue to launch your focus, flow, productivity, and verbal fluidity. Formulated as a buccal troche, it will slowly release the ingredients into the cheek mucosa over 15 to 30 minutes for a slow rise and easy off-ramp after 3 to 5 hours. Get yours now!
References
[1] V.S. Reddy, S. Shiva, S. Manikantan, S. Ramakrishna, Pharmacology of caffeine and its effects on the human body, European Journal of Medicinal Chemistry Reports 10 (2024) 100138. https://doi.org/10.1016/j.ejmcr.2024.100138.
[2] J.B. Murray, Nicotine as a psychoactive drug, J Psychol 125 (1991) 5–25. https://doi.org/10.1080/00223980.1991.10543265.
[3] L. Sansone, F. Milani, R. Fabrizi, M. Belli, M. Cristina, V. Zagà, A. De Iure, L. Cicconi, S. Bonassi, P. Russo, Nicotine: From Discovery to Biological Effects, IJMS 24 (2023) 14570. https://doi.org/10.3390/ijms241914570.
[4] H.R. Treloar, T.M. Piasecki, D.E. McCarthy, T.B. Baker, Relations Among Caffeine Consumption, Smoking, Smoking Urge, and Subjective Smoking Reinforcement in Daily Life, Journal of Caffeine Research 4 (2014) 93–99. https://doi.org/10.1089/jcr.2014.0007.
[5] J.L. Treur, A.E. Taylor, J.J. Ware, G. McMahon, J.-J. Hottenga, B.M.L. Baselmans, G. Willemsen, D.I. Boomsma, M.R. Munafò, J.M. Vink, Associations between smoking and caffeine consumption in two European cohorts: Smoking and caffeine consumption, Addiction 111 (2016) 1059–1068. https://doi.org/10.1111/add.13298.
[6] A. Nehlig, J.-L. Daval, G. Debry, Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects, Brain Research Reviews 17 (1992) 139–170. https://doi.org/10.1016/0165-0173(92)90012-B.
[7] J. Hukkanen, P. Jacob Iii, M. Peng, D. Dempsey, N.L. Benowitz, Effect of nicotine on cytochrome P450 1A2 activity, Brit J Clinical Pharma 72 (2011) 836–838. https://doi.org/10.1111/j.1365-2125.2011.04023.x.
[8] J.H. Bjørngaard, A.T. Nordestgaard, A.E. Taylor, J.L. Treur, M.E. Gabrielsen, M.R. Munafò, B.G. Nordestgaard, B.O. Åsvold, P. Romundstad, G. Davey Smith, Heavier smoking increases coffee consumption: findings from a Mendelian randomization analysis, International Journal of Epidemiology 46 (2017) 1958–1967. https://doi.org/10.1093/ije/dyx147.
[9] M. Napierała, J. Bogusiewicz, J. Enko, E. Florek, [Nicotine and caffeine: influence on dopaminergic transmission], Przegl Lek 73 (2016) 791–794.
[10] O. Cauli, M. Morelli, Caffeine and the dopaminergic system, Behav Pharmacol 16 (2005) 63–77. https://doi.org/10.1097/00008877-200503000-00001.
[11] H.E. Jones, R.R. Griffiths, Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers, Psychopharmacology (Berl) 165 (2003) 280–290. https://doi.org/10.1007/s00213-002-1262-4.
[12] Q. Wang, W. Du, H. Wang, P. Geng, Y. Sun, J. Zhang, W. Wang, X. Jin, Nicotine’s effect on cognition, a friend or foe?, Progress in Neuro-Psychopharmacology and Biological Psychiatry 124 (2023) 110723. https://doi.org/10.1016/j.pnpbp.2023.110723.
[13] A. Nehlig, Is Caffeine a Cognitive Enhancer?, JAD 20 (2010) S85–S94. https://doi.org/10.3233/JAD-2010-091315.
[14] P.A. Adeniyi, E.P. Omatsuli, A.J. Akinyemi, A.O. Ishola, Caffeine plus nicotine improves motor function, spatial and non-spatial working memory and functional indices in BALB/c male mice, Pathophysiology 23 (2016) 251–258. https://doi.org/10.1016/j.pathophys.2016.08.002.
[15] M. Nides, T. Danielsson, F. Saunders, R. Perfekt, R. Kapikian, J. Solla, S.J. Leischow, A. Myers, Efficacy and Safety of a Nicotine Mouth Spray for Smoking Cessation: A Randomized, Multicenter, Controlled Study in a Naturalistic Setting, Nicotine & Tobacco Research (2018). https://doi.org/10.1093/ntr/nty246.
[16] H. He, Z. Pan, J. Wu, C. Hu, L. Bai, J. Lyu, Health Effects of Tobacco at the Global, Regional, and National Levels: Results From the 2019 Global Burden of Disease Study, Nicotine & Tobacco Research 24 (2022) 864–870. https://doi.org/10.1093/ntr/ntab265.
[17] C. Gardiner, J. Weakley, L.M. Burke, G.D. Roach, C. Sargent, N. Maniar, A. Townshend, S.L. Halson, The effect of caffeine on subsequent sleep: A systematic review and meta-analysis, Sleep Medicine Reviews 69 (2023) 101764. https://doi.org/10.1016/j.smrv.2023.101764.
[18] J. Grgic, Are There Non-Responders to the Ergogenic Effects of Caffeine Ingestion on Exercise Performance?, Nutrients 10 (2018) 1736. https://doi.org/10.3390/nu10111736.
[19] E. Nohlert, J. Öhrvik, Á.R. Helgason, Non-responders in a quitline evaluation are more likely to be smokers – a drop-out and long-term follow-up study of the Swedish National Tobacco Quitline, Tob. Induced Dis. 14 (2016) 5. https://doi.org/10.1186/s12971-016-0070-2.
Comments (0)
There are no comments for this article. Be the first one to leave a message!